Drs. Kato and Kurzrock discuss the potential reasons why some cancer patients experience hyperprogression of disease while on immunotherapy treatment.
Shumei Kato, MD
Advertisement
Articles by Shumei Kato, MD
Advertisement
Latest Updated Articles
Razelle Kurzrock and Shumei Kato on Immunotherapy and Hyperprogression of DiseasePublished: April 15th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Chlorotoxin-Directed Cell Therapy May Have Useful Mechanism in Glioblastoma
2
Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC
3
Could Scorpion Venom Component Play a Role in Glioblastoma Management?
4
How Dato-DXd and the TROPION Trials Are Transforming Solid Tumor Research
5
